| George Batsides, MD | |
|
125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901-1962 | |
| (732) 235-7800 | |
| (732) 235-7013 |
| Full Name | George Batsides |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 27 Years |
| Location | 125 Paterson St, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992874705 | NPI | - | NPPES |
| 0084638 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 25MA07170600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger" - commonly, by breaking the action of a gene called p53 that puts the BH3 finger in motion. Now think of Bcl-2 as the switch itself.
FoodMinds, a food and nutrition company that harnesses science, public affairs and communications, is rolling into 2010 with new client partnerships and an expanding roster of full-time team members.
Human emotion system laboratory team at the University of Turku and Turku PET Centre, Finland, introduces a fully automated method for acute ischemic lesion segmentation on brain MRIs and shows how artificial intelligence can reduce the work load of radiologists.
A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.
› Verified 7 days ago
| Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger" - commonly, by breaking the action of a gene called p53 that puts the BH3 finger in motion. Now think of Bcl-2 as the switch itself.
FoodMinds, a food and nutrition company that harnesses science, public affairs and communications, is rolling into 2010 with new client partnerships and an expanding roster of full-time team members.
Human emotion system laboratory team at the University of Turku and Turku PET Centre, Finland, introduces a fully automated method for acute ischemic lesion segmentation on brain MRIs and shows how artificial intelligence can reduce the work load of radiologists.
A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.
› Verified 7 days ago
| Entity Name | Humc Cardiovascular Partners, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417188905 PECOS PAC ID: 6406996503 Enrollment ID: O20091222000199 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger" - commonly, by breaking the action of a gene called p53 that puts the BH3 finger in motion. Now think of Bcl-2 as the switch itself.
FoodMinds, a food and nutrition company that harnesses science, public affairs and communications, is rolling into 2010 with new client partnerships and an expanding roster of full-time team members.
Human emotion system laboratory team at the University of Turku and Turku PET Centre, Finland, introduces a fully automated method for acute ischemic lesion segmentation on brain MRIs and shows how artificial intelligence can reduce the work load of radiologists.
A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Batsides, MD 66 W Gilbert St, 2nd Floor, Tinton Falls, NJ 07701-4947 Ph: (732) 212-0051 | George Batsides, MD 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901-1962 Ph: (732) 235-7800 |
News Archive
Oncimmune LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in risk assessment and the early detection of lung cancer, today announced validation study results demonstrating the diagnostic and economic benefits of a standardized and reproducible autoantibody laboratory test that may significantly improve the prognosis for lung cancer patients.
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger" - commonly, by breaking the action of a gene called p53 that puts the BH3 finger in motion. Now think of Bcl-2 as the switch itself.
FoodMinds, a food and nutrition company that harnesses science, public affairs and communications, is rolling into 2010 with new client partnerships and an expanding roster of full-time team members.
Human emotion system laboratory team at the University of Turku and Turku PET Centre, Finland, introduces a fully automated method for acute ischemic lesion segmentation on brain MRIs and shows how artificial intelligence can reduce the work load of radiologists.
A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.
› Verified 7 days ago
John E Langenfeld, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7802 Fax: 732-235-7013 | |
Alan J Spotnitz, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson St, Clinical Academic Building - Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7800 Fax: 732-235-7013 | |
Dr. Benjamin Medina, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-235-4929 | |
Peter M Scholz, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson St, Suite 4100, New Brunswick, NJ 08901 Phone: 732-235-7800 | |
Dr. Manabu Takebe, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 4100, New Brunswick, NJ 08901 Phone: 732-235-6106 Fax: 732-235-2964 | |
Rachel Nemoyer, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 125 Pattersen St. Suite # 596, Meb Robert Wood Johnson University Hospital, New Brunswick, NJ 08901 Phone: 732-235-7674 | |
Ms. Adare Pampinella, PAC Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-828-3000 |